DK1427724T3 - Hidtil ukendt anvendelse af substituerede aminomethylchromaner - Google Patents
Hidtil ukendt anvendelse af substituerede aminomethylchromanerInfo
- Publication number
- DK1427724T3 DK1427724T3 DK02767363T DK02767363T DK1427724T3 DK 1427724 T3 DK1427724 T3 DK 1427724T3 DK 02767363 T DK02767363 T DK 02767363T DK 02767363 T DK02767363 T DK 02767363T DK 1427724 T3 DK1427724 T3 DK 1427724T3
- Authority
- DK
- Denmark
- Prior art keywords
- hitherto unknown
- substituted aminomethyl
- unknown use
- chromanes
- aminomethyl chromanes
- Prior art date
Links
- BSRHATGBRQMDRF-UHFFFAOYSA-N 3,4-dihydro-2h-chromen-2-ylmethanamine Chemical class C1=CC=C2OC(CN)CCC2=C1 BSRHATGBRQMDRF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01122377 | 2001-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1427724T3 true DK1427724T3 (da) | 2006-08-21 |
Family
ID=8178662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02767363T DK1427724T3 (da) | 2001-09-19 | 2002-08-12 | Hidtil ukendt anvendelse af substituerede aminomethylchromaner |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7618988B2 (da) |
| EP (1) | EP1427724B1 (da) |
| JP (1) | JP4615857B2 (da) |
| KR (1) | KR100912911B1 (da) |
| CN (1) | CN100338060C (da) |
| AR (1) | AR036677A1 (da) |
| AT (1) | ATE325120T1 (da) |
| AU (1) | AU2002331229B2 (da) |
| BR (1) | BR0212555A (da) |
| CA (1) | CA2460696C (da) |
| CY (1) | CY1105118T1 (da) |
| DE (1) | DE60211186T2 (da) |
| DK (1) | DK1427724T3 (da) |
| ES (1) | ES2262840T3 (da) |
| HU (1) | HUP0401910A3 (da) |
| MX (1) | MXPA04002492A (da) |
| MY (1) | MY128882A (da) |
| PE (1) | PE20030428A1 (da) |
| PL (1) | PL208787B1 (da) |
| PT (1) | PT1427724E (da) |
| RU (1) | RU2322443C2 (da) |
| SI (1) | SI1427724T1 (da) |
| TW (1) | TWI244391B (da) |
| WO (1) | WO2003024960A1 (da) |
| ZA (1) | ZA200402855B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10318690B3 (de) * | 2003-04-24 | 2004-11-11 | Merck Patent Gmbh | Verfahren zur Herstellung von Nicotinaldehyden |
| FR2978916B1 (fr) | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| RU2670272C2 (ru) * | 2012-04-18 | 2018-10-22 | Контера Фарма Апс | Пероральная фармацевтическая композиция, подходящая для повышения эффективности лечения двигательных нарушений |
| FR3001894A1 (fr) | 2013-02-08 | 2014-08-15 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| KR102443161B1 (ko) | 2016-07-11 | 2022-09-14 | 콘테라 파르마 에이/에스 | 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5767132A (en) * | 1980-10-07 | 1982-04-23 | Nippon Steel Corp | Vertical type continuous annealing furnace having independently moving middle partition plate |
| DE4135474A1 (de) * | 1991-10-28 | 1993-04-29 | Bayer Ag | 2-aminomethyl-chromane |
| SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
| DE69433401T2 (de) * | 1993-08-19 | 2004-09-16 | Janssen Pharmaceutica N.V. | Gefässverengende dihydrobenzopyranderivate |
| SI0707007T1 (en) * | 1994-10-14 | 2002-04-30 | Merck Patent Gmbh | (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent |
| US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
| US5756521A (en) * | 1996-04-03 | 1998-05-26 | American Home Products Corporation | Chroman-2-ylmethylamino derivatives |
| UA73981C2 (en) * | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
-
2002
- 2002-08-12 PT PT02767363T patent/PT1427724E/pt unknown
- 2002-08-12 AT AT02767363T patent/ATE325120T1/de active
- 2002-08-12 ES ES02767363T patent/ES2262840T3/es not_active Expired - Lifetime
- 2002-08-12 EP EP02767363A patent/EP1427724B1/en not_active Expired - Lifetime
- 2002-08-12 US US10/489,960 patent/US7618988B2/en not_active Expired - Fee Related
- 2002-08-12 HU HU0401910A patent/HUP0401910A3/hu unknown
- 2002-08-12 PL PL369684A patent/PL208787B1/pl not_active IP Right Cessation
- 2002-08-12 RU RU2004112190/15A patent/RU2322443C2/ru not_active IP Right Cessation
- 2002-08-12 SI SI200230351T patent/SI1427724T1/sl unknown
- 2002-08-12 JP JP2003528807A patent/JP4615857B2/ja not_active Expired - Fee Related
- 2002-08-12 WO PCT/EP2002/009001 patent/WO2003024960A1/en active IP Right Grant
- 2002-08-12 DK DK02767363T patent/DK1427724T3/da active
- 2002-08-12 CN CNB028183266A patent/CN100338060C/zh not_active Expired - Fee Related
- 2002-08-12 CA CA2460696A patent/CA2460696C/en not_active Expired - Fee Related
- 2002-08-12 KR KR1020047002484A patent/KR100912911B1/ko not_active IP Right Cessation
- 2002-08-12 AU AU2002331229A patent/AU2002331229B2/en not_active Ceased
- 2002-08-12 BR BR0212555-2A patent/BR0212555A/pt not_active IP Right Cessation
- 2002-08-12 MX MXPA04002492A patent/MXPA04002492A/es active IP Right Grant
- 2002-08-12 DE DE60211186T patent/DE60211186T2/de not_active Expired - Lifetime
- 2002-08-13 TW TW091118183A patent/TWI244391B/zh not_active IP Right Cessation
- 2002-09-16 MY MYPI20023438A patent/MY128882A/en unknown
- 2002-09-17 PE PE2002000915A patent/PE20030428A1/es not_active Application Discontinuation
- 2002-09-18 AR ARP020103509A patent/AR036677A1/es unknown
-
2004
- 2004-04-15 ZA ZA200402855A patent/ZA200402855B/en unknown
-
2006
- 2006-07-28 CY CY20061101061T patent/CY1105118T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1438306T3 (da) | Derivater af UK-2A | |
| DK1360169T3 (da) | Succinatsalt af O-desmethyl-venlafaxin | |
| DK1390377T3 (da) | Ny krystalform af azithromycin | |
| DK1417180T3 (da) | Fremstilling af aminopyrimidinforbindelser | |
| DK1410012T3 (da) | Bestemmelse af graviditetstilstand | |
| DK1458447T3 (da) | Kombination af cytokrom-p450-beroende proteasinhibitorer | |
| NO20035314D0 (no) | Ammunisjon med dobbelt kjerne | |
| DK1401828T3 (da) | N-Formylhydroxylaminforbindelser som inhibitorer af PDF | |
| DK1516540T3 (da) | Anvendelse af vitamin D-forbindelser | |
| NO20041968L (no) | Anvendelse av cystationin | |
| DK1377544T3 (da) | Oprensning af 2-nitro-4-methylsulfonylbenzoesyre | |
| IS6884A (is) | Aðferðir við að nýta líffræðilegan fjölbreytileika | |
| DK1427724T3 (da) | Hidtil ukendt anvendelse af substituerede aminomethylchromaner | |
| DK1373898T3 (da) | Påvisning af inflammationer | |
| FI20012295A0 (fi) | Hyvyysluku | |
| NO20033163L (no) | Ny anvendelse av iloperidon | |
| DE60130812D1 (de) | Okularlinse | |
| ITBA20010029U1 (it) | Gioiello di puglia | |
| ITGE20010022U1 (it) | Orologio | |
| DK1432452T3 (da) | Inhibering af STAT-1 | |
| ES1048744Y (es) | Plomada | |
| ITMN20010023A0 (it) | Gioiello | |
| UA5775S (uk) | Комплект етикеток | |
| UA5988S (uk) | Комплект етикеток | |
| UA7542S (uk) | Комплект етикеток |